Headlines

Additional European Equity News - 1st September 2026

In our morning note

EU Market Open, . It led with:

US Treasury Secretary Bessent told Japanese officials that rate hikes are needed, according to NHK; a Japanese MoF official expects the BoJ to act on the economy and not on US influence.

Nikkei 225 traded indecisively; USD/JPY traded rangebound, and 10yr JGB futures followed the declines in global peers.

Read the whole note Free to read.

Get the next one free, by email.

Both market-open notes, EU and US, every weekday. No account needed. Unsubscribe any time.

If you trade

This headline was on the Newsquawk live feed at .

Use the Platform opens our news terminal in your browser, with the live headline feed. It’s news, not a broker.

Moved markets ·

Fed’s Waller (voter) says more rate hikes are likely needed to tame inflation, but there is flexibility over the pace and hikes do not need to be consecutive.

DXY, after we published+0.1%

Use the Platform

Free. No signup, no card.

Aedifica (AED BB) - H1 2026 (EUR): Rental Income 292.3mln, +62% Y/Y; EPRA EPS 2.71, +5% Y/Y. Guides FY26 EPRA EPS at 5.35 and says that expected synergies will accelerate further, reaching a full run-rate impact of at least EUR 16mln during 2027. (Aedifica)

AstraZeneca (AZN LN) - Co. announces that its Tagrisso plus Orpathys demonstrated statistically significant and highly clinically meaningful improvement in progression-free survival in 1st-line MET-overexpressing EGFR-mutated lung cancer. Additionally, the Co. announces that they have acquired worldwide rights to develop and commercialise Zegfrovy. Furthermore, the Co. says Enhertu has been approved in the EU for 1L HER2-positive metastatic breast cancer, based on the Destiny-Breast09 phase III trial. (AstraZeneca)

Bavarian Nordic (BAVA DC) - Co. launches the first tranche of its DKK 750mln share buyback programme. The first tranche will result in DKK 250mln of share buybacks. (Bavarian Nordic)

Bunzl (BNZL LN) - H1 2026 (GBP): Revenue 5.93bln (prev. 5.76bln Y/Y), Adj. Operating Profit 440.6mln (prev. 404.5mln Y/Y), Adj. EPS 0.877 (prev. 0.778 Y/Y). Raises its FY26 guidance, now sees operating margin to be broadly flat Y/Y (prev. guided slightly down Y/Y). Announces a new GBP 500mln share buyback programme. (Bunzl)

DHL Group (DHL GY) - Co. says its Global Forwarding unit has acquired Uruguay's Aero Cargas; no terms disclosed. Elsewhere, the Co. announces that it has completed its corporate reorganisation. Under the reorganisation, Germany's Mail and Parcel business will continue to operate under Deutsche Post. (T21/DHL)

GSK (GSK LN) - Co. announces positive phase II data for its mRNA seasonal influenza vaccine candidate and intends to start a phase III efficacy trial in September 2026. (GSK)

London Stock Exchange (LSEG LN) - Co. announces plans to launch UK tokenised equity structures and forms a partnership with Payward. (LSEG)

UK Housing - Nationwide Housing Prices (Aug YY) 1.6% vs. Exp. 2.1% (Prev. 1.4%); MM 0.2% vs. Exp. 0.1% (Prev. -0.1%). (Nationwide)

Veolia (VIE FP) - Co. signs 3 strategic MoUs with companies in Saudi Arabia in water technologies and hazardous waste management. (Veolia)

Vodafone (VOD LN) - Co. announces that OXG, its fibre JV in Germany, will have a new shareholder. (Vodafone)

Accor (AC FP) reinitiated with Buy at Deutsche Bank

More on this story

Related headlines